M S Brown1, M J Hayes2, L M Thornton3. 1. Department of Pediatrics, Eastern Maine Medical Center, Bangor, ME, USA. 2. Department of Psychology & Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA. 3. Department of Pharmacy, Eastern Maine Medical Center, Bangor, ME, USA.
Abstract
OBJECTIVE: Compare duration of treatment of neonatal abstinence syndrome between methadone and morphine. STUDY DESIGN: A prospective, double-masked, randomized trial at a single site. Randomization of methadone or morphine was stratified for maternal treatment with methadone or buprenorphine. Inclusion criteria were (i) maternal treatment with prescribed methadone or buprenorphine, (ii) withdrawal treatment criteria, (iii) adjusted gestational age ⩾35(0/7) weeks and (iv) medically stable. Primary outcome was length of opioid treatment. RESULT: From January 2011 through October 2012, 78 infants were eligible for the study: 41 methadone-exposed and 37 buprenorphine-exposed. Consent was obtained from 31 mothers, 13/41 (32%) methadone-treated and 18/37 (49%) buprenorphine-treated. Length of opioid treatment was significantly shorter for methadone than morphine treatment, median 14 versus 21 days (P=0.008). CONCLUSION:Methadone had a shorter length of neonatal withdrawal treatment compared with morphine. Owing to the smaller sample size and single site, a larger randomized study is needed.
RCT Entities:
OBJECTIVE: Compare duration of treatment of neonatal abstinence syndrome between methadone and morphine. STUDY DESIGN: A prospective, double-masked, randomized trial at a single site. Randomization of methadone or morphine was stratified for maternal treatment with methadone or buprenorphine. Inclusion criteria were (i) maternal treatment with prescribed methadone or buprenorphine, (ii) withdrawal treatment criteria, (iii) adjusted gestational age ⩾35(0/7) weeks and (iv) medically stable. Primary outcome was length of opioid treatment. RESULT: From January 2011 through October 2012, 78 infants were eligible for the study: 41 methadone-exposed and 37 buprenorphine-exposed. Consent was obtained from 31 mothers, 13/41 (32%) methadone-treated and 18/37 (49%) buprenorphine-treated. Length of opioid treatment was significantly shorter for methadone than morphine treatment, median 14 versus 21 days (P=0.008). CONCLUSION:Methadone had a shorter length of neonatal withdrawal treatment compared with morphine. Owing to the smaller sample size and single site, a larger randomized study is needed.
Authors: Hendrée E Jones; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Amelia M Arria; Kevin E O'Grady; Peter Selby; Peter R Martin; Gabriele Fischer Journal: N Engl J Med Date: 2010-12-09 Impact factor: 91.245
Authors: Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis Journal: JAMA Date: 2012-04-30 Impact factor: 56.272
Authors: Hendree E Jones; Rolley E Johnson; Donald R Jasinski; Kevin E O'Grady; Christian A Chisholm; Robin E Choo; Michael Crocetti; Robert Dudas; Cheryl Harrow; Marilyn A Huestis; Lauren M Jansson; Michael Lantz; Barry M Lester; Lorraine Milio Journal: Drug Alcohol Depend Date: 2005-07 Impact factor: 4.492
Authors: Walter K Kraft; Eric Gibson; Kevin Dysart; Vidula S Damle; Jennifer L Larusso; Jay S Greenspan; David E Moody; Karol Kaltenbach; Michelle E Ehrlich Journal: Pediatrics Date: 2008-08-11 Impact factor: 7.124
Authors: Robert M Ward; David R Drover; Gregory B Hammer; Christopher J Stemland; Steve Kern; Martin Tristani-Firouzi; Ralph A Lugo; Kristin Satterfield; Brian J Anderson Journal: Paediatr Anaesth Date: 2014-03-26 Impact factor: 2.556
Authors: Stephen W Patrick; Robert E Schumacher; Jeffrey D Horbar; Madge E Buus-Frank; Erika M Edwards; Kate A Morrow; Karla R Ferrelli; Alan P Picarillo; Munish Gupta; Roger F Soll Journal: Pediatrics Date: 2016-04-15 Impact factor: 7.124
Authors: Elisha M Wachman; Marie J Hayes; Richard Sherva; Mark S Brown; Hira Shrestha; Beth A Logan; Nicole A Heller; David A Nielsen; Lindsay A Farrer Journal: Am J Addict Date: 2016-12-16
Authors: Jason R Pryor; Faouzi I Maalouf; Elizabeth E Krans; Robert E Schumacher; William O Cooper; Stephen W Patrick Journal: Arch Dis Child Fetal Neonatal Ed Date: 2017-01-10 Impact factor: 5.747
Authors: Matthew R Grossman; Adam K Berkwitt; Rachel R Osborn; Yaqing Xu; Denise A Esserman; Eugene D Shapiro; Matthew J Bizzarro Journal: Pediatrics Date: 2017-05-18 Impact factor: 7.124
Authors: Brian J Piper; Clare E Desrosiers; John W Lipovsky; Matthew A Rodney; Robert P Baker; Kenneth L McCall; Stephanie D Nichols; Sarah L Martin Journal: J Stud Alcohol Drugs Date: 2016-07 Impact factor: 2.582
Authors: Jason R Wiles; Barbara Isemann; Tomoyuki Mizuno; Meredith E Tabangin; Laura P Ward; Henry Akinbi; Alexander A Vinks Journal: J Pediatr Date: 2015-09-11 Impact factor: 4.406